4.7/5 - (1365 votes)

Tumor markers are substances that can be detected in patients by laboratory diagnostic tools and that indicate the presence or development of a tumor in the body. One such marker is chorionic gonadotropin (hCG), which is commonly associated with the development of thromboplastic tumors. In this text, we will consider how hCG can be used to diagnose such tumors and how this information can be useful in clinical practice.

HCG – what is it?

Human Chorionic Gonadotropin (hCG) is a hormone produced by the placenta during pregnancy. It is responsible for supporting the yolk sac and producing progesterone, which is necessary to maintain pregnancy. However, hCG can also be produced by tumors, particularly thromboplastic tumors.

Diagnosis of thromboplastic tumors

Thromboplastic tumors are a group of tumors that develop from cells that form plasma elements of the blood, such as platelets. This group includes leukemia, lymphoma, and other hematological tumors. It is important to use various methods to diagnose such tumors, and one of them is the determination of the level of chorionic gonadotropin.

hCG determination in tumor diagnosis

It is important to note that hCG may be elevated not only in thromboplastic tumors, but also in other diseases such as pregnancy, acute or chronic kidney disease, ovarian pathology, and many other conditions. Also, elevated hCG levels can be observed in some normal situations, for example, in pregnant women. Therefore, it is important to consider all clinical and laboratory data when evaluating hCG levels.

Various methods can be used to determine hCG levels, including blood tests and urine tests. It is usually important to determine the dynamics of hCG levels over time for the diagnosis of tumors. In thromboplastic tumors, abnormally increased hCG levels are observed, and this may serve as a basis for further examinations, such as biopsy, ultrasound, and other examination methods.

Application of hCG diagnostics in clinical practice

The determination of hCG levels has important practical applications in oncology and hematology. In thromboplastic tumors, such as leukemia or lymphoma, the detection of elevated hCG levels can help in timely diagnosis and selection of effective treatment. In addition, monitoring hCG levels after treatment can serve as an indicator of the effectiveness of therapy and can help in the early detection of relapse.

Conclusion

Chorionic gonadotropin (hCG) is an important tumor marker that can be used to diagnose thromboplastic tumors, such as leukemia or lymphoma. However, elevated hCG levels can occur in a variety of conditions, so it is important to consider all clinical and laboratory data when evaluating this marker. Diagnostics and monitoring of hCG levels can be useful tools in clinical practice for the timely diagnosis and treatment of patients with thromboplastic tumors.